From the Editors of Pharmaceutical Executive

You are receiving this email as a subscriber to Pharmaceutical Executive

Interested in Learning About Other Topics? Give us your ideas for a Future Webcast or Podcast

*Webcasts:*
Thursday, November 4, 2010 at 11:00 AM ET; 8:00 AM PT Implementing a Comprehensive Aggregate Spend and Disclosure Solution to Ensure Compliance with US and International Regulations Compliance with US laws that require disclosure of promotion, marketing and advertising expenses represent a growing cost and administrative burden for life sciences companies. In addition, anti-bribery laws, such as FCPA, and a trend towards global transparency require companies to think beyond just compliance with US regulations. Join us to discuss the current regulatory environment on promotion disclosure and the growing responsibilities for companies to be more transparent with their promotional expenses. Hear about best practices that your peers implement to ensure effective and compliant processes within their organization and avoid common pitfalls in compliance. And learn about cost effective solutions to ensure uniform compliance with state and aggregate reporting requirement rules, including data collection and analysis, security protections, report distribution and management, and technology applications.
» Register Free!	Sponsored by: Cegedim Relationship Management

ON DEMAND Geographic Segmentation Without Reorganization Is it possible for pharmaceutical companies to develop and execute differentiated geographic strategies without resorting to radical organizational change? This webcast will demonstrate how newly available data enables marketing, sales and managed markets organizations to understand the relative importance or "sphere of influence" of physicians, managed care, and consumers in each distinct geographic area and will present a novel approach for managing these differences without reorganization.
» Register Free!	Sponsored by: Wolters Kluwer and Amundsen Group

ON DEMAND Release Higher Performance Through Business Analytics High performing companies have discovered how to harness the power of predictive capabilities to deliver top line sales growth, make smarter decisions and achieve better results. Predictive analytics is cited as the next management discipline, but relative to other industries many pharmaceutical companies have been late adopters in embracing this movement. Release Higher Performance through Business Analytics will help corporate decision makers like you better understand why predictive analytics is a game changer for sales and marketing, how to address the unique challenges in adopting this discipline and overcome barriers to implementation. Join us for our video webcast and listen in as our expert panel debate and give insights into leadership, process, talent and technology for Next Generation Business Analytics.
» Register Free!	Sponsored by: SAS

Podcasts:

Trends in Patient Access: How Health Reform, Cost of Care and Stakeholder Response Will Shape Pharmaceutical Product Utilization
Questions abound over the impact that health reform and related measures will have on patients’ ability to receive the medications they want and need. Join us as we discuss what pharmaceutical manufacturers, payers, providers and patients are doing in response to this dynamic healthcare environment.

Sponsored by: AmerisourceBergen Specialty Group

Whitepapers:

Safety Document Exchange in the Global Clinical Research Environment
Serious Adverse Event (SAE) reporting can have severe repercussions both for patient safety and company reputation. By choosing a portal solution from a SaaS provider with state-of-the-art online security features, a sponsor or CRO can maintain real-time distribution and access reports for all documents shared, helping maintain compliance and data privacy.

» View Whitepaper